Cypher AI

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Cypher AI - overview

Established

2025

Location

Cambridge, MA, US

Primary Industry

Software

About

Cypher AI, based in Cambridge, US, specializes in providing a digital infrastructure tailored for life sciences research, enhancing data management and workflow automation through advanced AI-driven solutions. Founded in 2025, Cypher AI develops digital tools for life sciences research, focusing on automated data systems. The company's headquarters is located in Cambridge, US. The recent Seed funding round in May 2026 raised USD 2.


000 mn, led by MaC Venture Capital with participation from Epsilon Ventures, Connecticut Innovations, LiquidMetal Ventures, and Sparta Group, contributing to a total amount raised of USD 2. 000 mn. Cypher AI offers an integrated digital infrastructure specifically designed for life sciences research and development. The core product suite includes automated electronic laboratory notebooks (ELN), laboratory information management systems (LIMS), bioinformatics pipelines, and CRO marketplace orchestration tools.


These solutions enable scientists to articulate their needs in natural language, generating dynamic workflows and data management systems that adapt to experimental changes in real time. The platform enhances visibility, reproducibility, and institutional knowledge by integrating workflows, ensuring that every dataset created contributes to the organization’s collective expertise. Cypher AI serves a diverse client base that includes mid-sized contract research organizations (CROs), biopharmaceutical companies, and academic institutions across North America, Europe, and Asia, catering to their need for streamlined operations and reduced friction in research processes. Cypher AI generates revenue through a subscription-based model.


Clients in the life sciences sector pay annual or monthly fees for access to the platform's functionalities, including LIMS, ELN, and automated data pipelines. Partnerships often involve tailored solutions, facilitating the seamless integration of Cypher's tools into existing infrastructures with pricing options available for various client needs, including enterprise solutions for larger organizations. In May 2026, Cypher AI raised USD 2. 000 mn in Seed funding, which will be utilized to expand operations and continue developing its AI-based platform for life science research.


The company aims to enhance its product offerings and is exploring entry into new geographic markets to support its growth initiatives.


Current Investors

Connecticut Innovations, Sparta Group, MaC Venture Capital

Primary Industry

Software

Sub Industries

Analytics & Performance Software, Application Integration Software, Content Management Software, Scientific Software

Website

www.cypherbio.ai

Verticals

Artificial Intelligence, Cloud Computing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.